Chloé P.
- Country
- France
- Department
- Neurology
Research Overview
- Evaluation of LY3541860 Versus Placebo in Reducing New T1 Gadolinium-Enhancing Lesions in Adults with Relapsing Multiple Sclerosis
- Phase 3 Randomized, Double-Blind Study of Frexalimab (SAR441344) Versus Placebo in Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
- A Multi-Center, Double-Blind, Placebo-Controlled, Phase II Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489, A Monoacylglycerol Lipase Inhibitor, as Add-On Therapy to Ocrelizumab, in Participants with Progressive Forms of Multiple Sclerosis
Data & Insights
Has run more than one trial at 43 of 190 partner sites.
Specializations
Neurological Disorders
This investigator specializes in the study of relapsing multiple sclerosis, focusing on innovative therapeutic approaches for managing this neurological condition.
- Central Nervous System Disorders
- Autoimmune Neurological Conditions
- Multiple Sclerosis Treatment
The investigator's work involves evaluating advanced therapeutic interventions for patients with relapsing forms of multiple sclerosis.
Neuroimaging Research
The investigator utilizes advanced MRI brain imaging techniques to assess treatment effectiveness in neurological conditions.
- Brain Lesion Assessment
- Gadolinium-Enhanced MRI
- Neurological Imaging Protocols
Their expertise includes specialized imaging techniques for monitoring disease progression and treatment response in multiple sclerosis.
Treatment Innovation
The investigator explores novel therapeutic approaches for managing relapsing multiple sclerosis, with a focus on emerging treatment options.
- Experimental Therapeutics
- Disease-Modifying Treatments
- Clinical Efficacy Assessment
Their research encompasses the evaluation of new therapeutic agents for improving patient outcomes in multiple sclerosis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.